State-of-the-art chemoradiation is no substitution for trimodality approach in the treatment of locally advanced thoracic esophageal squamous cell carcinoma.
Asian J Surg
; 46(8): 3383-3384, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-36990809
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Esophageal Neoplasms
/
Carcinoma, Squamous Cell
/
Esophageal Squamous Cell Carcinoma
Limits:
Humans
Language:
En
Journal:
Asian J Surg
Year:
2023
Document type:
Article
Country of publication:
Países Bajos